XORTX Therapeutics Inc. (TSXV:XRTX)
Canada · Delayed Price · Currency is CAD 3.050
-0.040 (-1.29%)
At close: Aug 27, 2026
XORTX Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 0.99 | 0.86 | 2.47 | 3.45 | 10.43 | 14.87 |
Cash & Short-Term Investments | 0.99 | 0.86 | 2.47 | 3.45 | 10.43 | 14.87 |
Cash Growth | -6.53% | -65.05% | -28.25% | -66.96% | -29.83% | 10962.65% |
Other Receivables | 0.09 | 0.08 | 0.02 | 0.06 | 0.08 | 0.04 |
Receivables | 0.09 | 0.08 | 0.02 | 0.06 | 0.08 | 0.04 |
Prepaid Expenses | 1.35 | 0.02 | 0.18 | 0.24 | 0.38 | 0.44 |
Other Current Assets | - | 0.29 | 0 | 0.32 | - | 0.56 |
Total Current Assets | 2.44 | 1.26 | 2.68 | 4.07 | 10.9 | 15.91 |
Property, Plant & Equipment | - | 0.04 | 0.03 | 0.02 | 0.09 | - |
Other Intangible Assets | 2.55 | 0.19 | 0.18 | 0.18 | 0.2 | 0.2 |
Other Long-Term Assets | 1.2 | 1.2 | 1.2 | 1.2 | 1.19 | 1.27 |
Total Assets | 6.18 | 2.68 | 4.09 | 5.47 | 12.37 | 17.38 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Accounts Payable | 0.56 | 0.4 | 0.08 | 0.2 | 1.29 | 0.32 |
Accrued Expenses | 0.12 | 0.16 | 0.06 | 0.09 | 0.15 | 0.23 |
Current Portion of Leases | - | 0.04 | 0.04 | 0.01 | 0.07 | - |
Other Current Liabilities | 0 | 0.01 | 0.57 | 0.53 | - | - |
Total Current Liabilities | 0.68 | 0.6 | 0.76 | 0.83 | 1.51 | 0.55 |
Long-Term Leases | - | - | - | - | 0.01 | - |
Other Long-Term Liabilities | - | - | - | - | 3.85 | 3.63 |
Total Liabilities | 0.68 | 0.6 | 0.76 | 0.83 | 5.38 | 4.18 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Common Stock | 20.8 | 20.18 | 18.49 | 17.06 | 16.52 | 16.09 |
Retained Earnings | -26.32 | -23.82 | -21.17 | -17.85 | -15.7 | -7.98 |
Comprehensive Income & Other | 11.02 | 5.73 | 6.01 | 5.44 | 6.17 | 5.09 |
Shareholders' Equity | 5.5 | 2.08 | 3.34 | 4.64 | 7 | 13.2 |
Total Liabilities & Equity | 6.18 | 2.68 | 4.09 | 5.47 | 12.37 | 17.38 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Total Debt | - | 0.04 | 0.04 | 0.01 | 0.08 | - |
Net Cash (Debt) | 0.99 | 0.83 | 2.43 | 3.44 | 10.36 | 14.87 |
Net Cash Growth | 1.12% | -66.03% | -29.14% | -66.82% | -30.35% | 10962.65% |
Net Cash Per Share | 0.75 | 0.87 | 4.23 | 8.67 | 34.99 | 67.95 |
Filing Date Shares Outstanding | 1.82 | 1.39 | 0.76 | 0.58 | 0.4 | 0.29 |
Total Common Shares Outstanding | 1.73 | 1.39 | 0.7 | 0.4 | 0.33 | 0.29 |
Working Capital | 1.76 | 0.66 | 1.92 | 3.24 | 9.38 | 15.36 |
Book Value Per Share | 3.18 | 1.50 | 4.79 | 11.61 | 20.95 | 45.74 |
Tangible Book Value | 2.96 | 1.9 | 3.15 | 4.47 | 6.8 | 13 |
Tangible Book Value Per Share | 1.71 | 1.36 | 4.53 | 11.17 | 20.35 | 45.04 |
Machinery | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | - |